MSF and TB activists disrupt opening of TB conference to protest drug corporations keeping life-saving medicines from people
October 30, 2019Newer medicines for DR-TB are desperately needed, but barriers to access, including high prices, keep them out of reach for most people around the world. Hyderabad, 30 October – Doctors Without Borders/Médecins Sans Frontières (MSF) joined tuberculosis (TB) activists to disrupt...
Read more
MSF urges PM Modi not to make any trade commitments to US threatening access to medicines
September 20, 2019Ahead of the Prime Minister Narendra Modi’s visit to the US to discuss a ‘trade-package’ with the US President Donald Trump, Médecins Sans Frontières/ Doctors Without Borders (MSF) urges the Indian government to not make any commitments regarding intellectual property,...
Read more
Gilead Sciences fails on promise to expand access to lifesaving drug for people living with HIV
June 27, 2019Inaction by US pharmaceutical corporation Gilead to follow through on its so-called ‘access initiative’ leaves people unable to access a vital drug to treat a deadly infection. Delhi/Geneva - Pharmaceutical corporation Gilead Sciences has failed to deliver on promises to make...
Read more
MSF: U.S. Special 301 report undermines efforts to lower medicine prices globally
April 26, 2019On the eve of World Intellectual Property Day, the United States Trade Representative released its annual “Special 301 Report.” Developing countries like India and Malaysia once again face unfair pressure from the US government over the measures these countries have...
Read more
Tuberculosis: TB activists challenge Johnson & Johnson patent application on bedaquiline in India
February 14, 2019Mumbai/Cape Town - Doctors Without Borders/Médecins Sans Frontières (MSF) is supporting a patent challenge filed in India this week by two tuberculosis survivors, to prevent pharmaceutical corporation Johnson & Johnson (J&J) from extending its monopoly on the tuberculosis drug bedaquiline. Nandita...
Read more
Tuberculosis: TB activists challenge Johnson & Johnson patent application on bedaquiline in India
February 8, 2019Mumbai/Cape Town - Doctors Without Borders/Médecins Sans Frontières (MSF) is supporting a patent challenge filed in India this week by two tuberculosis survivors, to prevent pharmaceutical corporation Johnson & Johnson (J&J) from extending its monopoly on the tuberculosis drug bedaquiline....
Read more
Access to medicines
February 6, 2019Unaffordable, unavailable, not adapted - people around the world face these challenges in accessing lifesaving medicines. During the 1990s, MSF teams made a bitter observation: we were failing to treat some of our patients suffering from infectious diseases, while in...
Read more
Access Campaign
January 28, 2019MSF in India: Projects in India Access Campaign Contact us A worldwide campaign for affordable and effective medicines In 1999, in the wake of Doctors Without Borders / Médecins Sans Frontières (MSF) being awarded the Nobel Peace Prize, MSF launched...
Read more
ASEAN and India urged not to trade away people’s lives in trade agreement
July 20, 2018RCEP trade deal could cut medicines lifeline for people in developing countries Bangkok/Geneva - As the sixteen countries negotiating Regional Comprehensive Economic Partnership (RCEP) trade agreement meet in Bangkok this week for another round of closed-door negotiations, public health experts and...
Read more
People living with hepatitis C and HIV challenge evergreening patents on lifesaving hepatitis C drugs in India
July 10, 2018Doctors Without Borders/Médecins Sans Frontières (MSF) welcomes two patent oppositions filed by Delhi Network of Positive People (DNP+) before the Indian patent office, challenging additional patent claims by US pharmaceutical corporation-Gilead Sciences for the hepatitis C medicines sofosbuvir and velpatasvir....
Read more
